Volume 111, Issue 5 , Pages 947-951, May 2003
Schistosoma mansoni infection is associated with a reduced course of asthma1
Background:
Helminthic infections decrease skin reactivity to indoor allergens, but data on whether they influence asthma severity are lacking.
Objective:
This study evaluated the course of asthma in patients with and without Schistosoma mansoni infection.
Methods:
Asthmatic subjects were enrolled from 3 low-socioeconomic areas: a rural area endemic for schistosomiasis (group 1) in addition to a rural area (group 2) and a slum area (group 3), both of which were not endemic for schistosomiasis. A questionnaire on the basis of the International Study of Asthma and Allergies in Childhood study was applied in these 3 areas, and from each area, 21 age- and sex-matched asthmatic subjects were selected for a prospective 1-year study. Pulmonary function tests, skin prick tests with indoor allergens, stool examinations, and serum evaluations were performed in these subjects. Every 3 months, the subjects were evaluated for asthma exacerbation through physical examination, and a questionnaire regarding asthma symptoms and use of antiasthma medicine was administered.
Results:
The prevalence of S mansoni infection was greater in group 1 compared with in groups 2 and 3 (P<.0001), whereas the frequency of other helminth and protozoa infections was similar among the 3 groups. The frequency of positive skin test responses to indoor allergens was less (19.0%) in group 1 subjects relative to those in group 2 (76.2%) and group 3 (57.1%; P<.001). The frequencies of symptoms, use of antiasthma drugs, and pulmonary abnormal findings at physical examination were less in group 1 subjects than in group 2 and 3 subjects (P=.0001).
Conclusion:
Our results suggest that S mansoni infection is associated with a milder course of asthma.
Key words: Asthma, skin prick test, dust mites, helminths, Schistosoma mansoni, IL-10, IgE
No full text is available. To read the body of this article, please view the PDF online.
1 Supported by the Fundação de Apoio a Pesquisa do Estado da Bahia (FAPESB) and Conselho Nacional de Pesquisa (CNPq) through Instituto de Investigação em Imunologia (iii). Edgar M. Carvalho is Senior Investigator of CNPq.
PII: S0091-6749(03)80119-7
doi:10.1067/mai.2003.1381
© 2003 Published by Elsevier Inc.
Volume 111, Issue 5 , Pages 947-951, May 2003
